// App-Quantinova.ai

: Idiopathic pulmonary fibrosis (IPF: observations from a Phase 2 trial of GLPG1205 (PINTA

Researchers

Presenter

  • Irina Ruxandra Strambu

Principal Investigators

  • Liesbeth Fagard

  • Paul Ford

  • Tom Van Der Aa

  • Angela De Haas-Amatsaleh

  • Eva Santermans

  • Christian Seemayer

Medical Centers

  • University of Medicine and Pharmacy Carol Davila, Bucharest, Romania

  • Galapagos, Mechelen, Belgium

Locations

  • Romania

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • GLPG1205

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • NCT03725852

Sponsors

  • Galapagos

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved